More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary HempMeds® Broadens Offerings to Include CBN and CBG as Part of Company’s Updated Brand Strategy

Medical Marijuana, Inc. Subsidiary HempMeds® Broadens Offerings to Include CBN and CBG as Part of Company’s Updated Brand Strategy

by adminAdrianRamirez | Jan 5, 2021 | HempMeds, Press Releases

SAN DIEGO, CA, Jan. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical...
Medical Marijuana, Inc. Subsidiary HempMeds® Announces Updated Branding Strategy to Accompany Change in Executive Leadership

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Updated Branding Strategy to Accompany Change in Executive Leadership

by adminAdrianRamirez | Dec 15, 2020 | HempMeds, Press Releases

SAN DIEGO, Dec. 15, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived...
Medical Marijuana, Inc. Subsidiary HempMeds® Names Renowned Cannabis Leader Raul Elizalde as CEO and Matheus Patelli as Managing Director of Brazil Operations

Medical Marijuana, Inc. Subsidiary HempMeds® Names Renowned Cannabis Leader Raul Elizalde as CEO and Matheus Patelli as Managing Director of Brazil Operations

by adminAdrianRamirez | Nov 19, 2020 | HempMeds, Press Releases

Promotes International Executive Team to Further Capitalize on Growing CBD Market in Latin America SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly...
HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches CBD Topical and Beauty Products at Gelson’s Market

HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches CBD Topical and Beauty Products at Gelson’s Market

by adminAdrianRamirez | Jul 7, 2020 | HempMeds, Press Releases

SAN DIEGO, July 07, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived...
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance

Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance

by adminAdrianRamirez | Jun 30, 2020 | HempMeds, Press Releases

SAN DIEGO, June 30, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...
Medical Marijuana, Inc. Subsidiary HempMeds® Appoints Vince DiMella as U.S. Director of Sales and Marketing

Medical Marijuana, Inc. Subsidiary HempMeds® Appoints Vince DiMella as U.S. Director of Sales and Marketing

by adminAdrianRamirez | Jun 16, 2020 | HempMeds, Press Releases

SAN DIEGO, June 16, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.